Marotta Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
RG
CDDEC
BTCPP
AAMU
ISS
Marotta Asset Management's AZN Position: Q2 2026 in Review
Marotta Asset Management sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 4,959 shares — an estimated $995K sold.
Marotta Asset Management first reported a position in AZN in Q1 2021 and held it in 20 quarters. The position peaked at $1.03M in Q2 2024. 700 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Marotta Asset Management reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
- Marotta Asset Management sold 4,959 AstraZeneca shares in Q2 2026, an estimated $995K.
- Marotta Asset Management first reported a position in AstraZeneca in Q1 2021 and held it in 20 quarters.
- Marotta Asset Management's AstraZeneca position peaked at $1.03M in Q2 2024.
- 700 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Marotta Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.